Federal Appeals Court Questions Biden Administration's Abortion Pill Policy

A federal appeals court panel heard arguments on whether the FDA's approval of the abortion pill, mifepristone, should be withdrawn. The case stems from a preliminary ruling by a federal judge in Texas who declared the FDA's approval of the pill invalid. The plaintiffs claim that mifepristone is unsafe and that the FDA did not follow proper regulatory protocols in approving it in 2000. The FDA and a manufacturer of mifepristone argued that the plaintiffs did not show they would suffer actual injuries if access and approval of the pill remains unchanged. The appeals court has not yet issued a decision.